Abstract
Aim
To analyze the clinical spectrum and the incidence of coronary involvement in infants with typical Kawasaki's disease (KD).
Patients and Methods
A retrospective study was performed on children one year of age or younger diagnosed from February 1992 to January 2006 with typical KD. Children with incomplete forms of the disease were not included.
Results
Twenty-five infants were diagnosed with KD during the study period. The median age of the patients was 10 months (range, 4–12 months). All children but one received intravenous gammaglobulin (IVIG), 84% before the 10th day of disease. Seven patients (28%) required the administration of more than one dose of IVIG, because persistence of fever. Coronary artery disease (CAD) was recorded in 6 cases (24%), five of them being boys. All patients with CAD were treated with ASA plus IVIG and 84% of them received this therapy within the first 10 days of the KD onset.
Conclusions
In spite of the exclusion of our study of incomplete presentations and of an early administration of IVIG in our patients, we have observed a high rate of infants who developed CAD, which is similar to the one reported in children who do not receive IVIG.
Similar content being viewed by others
References
Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB (2006) Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994–2003. Pediatr Infect Dis J 25:245–259
Centers for Disease Control and Prevention. National Center for Infectious Diseases, Atlanta, GA. Available at: http://www.cdc.gov/ncidod/diseases/kawasaki/index.htm. Accessed: November 17, 2006
Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH (2006) Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 25:241–244
Chang RR (2002) Hospitalizations for Kawasaki disease among children in the United States,1988–1997. Pediatrics 109:E87
Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY (2006) Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 39:387–391
Durongpisitkul K, Gurujai VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurism in Kawasaki disease: a meta analysis of the efficacy of aspirin and inmunoglobulin treatment. Pediatrics 96:1057–1061
Kato H, Sugimura T, Akagi T, et al. (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385
Martínez Ruiz M, del Castillo Martín F, Borque Andrés C, et al. (2003) Incidencia y características clínicas de la enfermedad de Kawasaki en nuestro medio. An Pediatr (Barc) 59:323–327
Nakamura Y, Fujita Y, Nagai M, et al. (1991) Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics 88:1144–1147
Newburger JW, Takahashi M, Gerber MA, et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733
Nomura Y, Yoshinaga M, Masuda K, Takei S, Miyata K (2002) Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome. J Infect Dis 185:1677–1680
Onouchi Z, Kawasaki T (1999) Overview of pharmacological treatment of Kawasaki disease. Drugs 58:813–822
Rosenfeld EA, Corydon KE, Shulman ST (1995) Kawasaki disease in infants less than one year of age. J Pediatr 126:524–529
Rowley AH, Shulman ST (1998) Kawasaki syndrome. Clin Microbiol Rev 11:405–414
Seve P, Stankovic K, Samil A, Durand DV, Marchand G, Broussolle C (2005) Adult Kawasaki disease: report of two cases and literature review. Semin Arth Rheum 34:785–792
Shulman ST, De Inocencio J, Hirsch R (1995) Kawasaki disease. Pediatr Clin North Am 42:1205–1222
Shulman ST, McAuley JB, Pachman LM, Miller ML, Ruschhaupt DG (1987) Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 141:420–425
Chang RR (2002) Hospitalizations for Kawasaki disease among children in the United States,1988–1997. Pediatrics 109:E87
Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY (2006) Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 39:387–391
Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387–389
Tseng CF, Fu YC, Fu LS, Betau H, Chi CS (2001) Clinical spectrum of Kawasaki disease in infants. Zhonghua Yi Xue Za Zhi (Taipen) 64:168–173
Yanagawa H, Nakamura Y, Yashiro M, et al. (2001) Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 107:E33
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreno, N., Méndez-Echevarría, A., de Inocencio, J. et al. Coronary Involvement in Infants with Kawasaki Disease Treated with Intravenous γ-Globulin. Pediatr Cardiol 29, 31–35 (2008). https://doi.org/10.1007/s00246-007-9068-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-007-9068-0